ETFs
Search documents
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
ZACKS· 2025-09-02 11:21
Core Insights - The iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed fund launched on May 1, 2006, aimed at providing broad exposure to the Healthcare - Pharma segment of the equity market [1] - The Healthcare - Pharma sector is ranked 7th among the 16 Zacks sectors, placing it in the top 44% [2] Fund Overview - Sponsored by Blackrock, IHE has assets exceeding $578.73 million, categorizing it as an average-sized ETF [3] - The fund seeks to match the performance of the Dow Jones U.S. Select Pharmaceuticals Index, which is a free-float adjusted market capitalization-weighted index [4] Cost Structure - IHE has an annual operating expense ratio of 0.38%, making it one of the cheaper options in the ETF space [5] - The ETF offers a 12-month trailing dividend yield of 1.64% [5] Sector Exposure and Holdings - The ETF is fully allocated to the Healthcare sector, with approximately 100% of its portfolio [6] - Johnson & Johnson (JNJ) constitutes about 25.45% of total assets, followed by Eli Lilly (LLY) and Viatris Inc (VTRS), with the top 10 holdings accounting for approximately 78.07% of total assets [7] Performance Metrics - As of September 2, 2025, IHE has gained roughly 9.19% this year but is down about 0.74% over the past year [8] - The ETF has traded between $61 and $72.85 in the last 52 weeks, with a beta of 0.54 and a standard deviation of 15.83% over the trailing three-year period, indicating a higher risk profile [8] Alternatives - IHE carries a Zacks ETF Rank of 3 (Hold), suggesting it is a reasonable option for investors seeking exposure to the Healthcare ETFs area [9] - Other ETF options include Invesco Pharmaceuticals ETF (PJP) and VanEck Pharmaceutical ETF (PPH), with respective assets of $259.99 million and $620.64 million [10]
X @Michaël van de Poppe
Michaël van de Poppe· 2025-09-01 20:22
RT MN Fund (@MNFund_)This week, our Investment Manager @cryptomichnl will be attending @conf3rence where he'll join a panel to discuss the upcoming period for the market.He'll be discussing everything related to #Bitcoin, $ETH, the ETFs, and which areas are interesting.Make sure to reach out if you'd like to meet up! ...
X @Ash Crypto
Ash Crypto· 2025-09-01 13:18
ETH is going to $8k-$10k in 6 months- Treasury Companies buying billions- ETFs buying Billions- Genius Act = stablecoins (Trillions)- Stocks coming to ETH chain with RWA- ETH staking rewards for ETFs- Deflationary supply- 29% already stakedLike this you are bullish ...
X @Xeer
Xeer· 2025-09-01 07:32
Investment Strategy - Dollar cost averaging ETFs are recommended for long-term investment [1] - Investors feeling uneasy with price action are likely overexposed [2] - Overconfidence in market knowledge is cautioned against [2] Risk Assessment - New investors should reconsider if crypto aligns with their risk appetite [2]
X @Bitget Wallet 🩵
Bitget Wallet 🩵· 2025-09-01 07:29
Big if trueOndo Finance (@OndoFinance):Historic week ahead.On September 3rd, 100+ tokenized stocks & ETFs come onchain.Flipping the switch to more open, global, and accessible capital markets. https://t.co/iVsB3WN0Q7 ...
NO ONE IS READY: XRP Will SHOCK The Entire Market
NCashOfficial - Daily Crypto & Finance News· 2025-08-31 16:00
Over the years, we have dealt with so much FUD around XRP. Initially, a lot of it was coming from, you know, Bitcoin maxis. Then it was coming from Ethereum maxis.Now you have chain link maxis hating on XRP. It just feels like XRP is the most hated crypto out there. And I seriously have no idea why.I don't know why XRP is so hated. I don't know why everyone dislikes what Ripple is doing. I just I really don't see the big problem here. I don't see why XRP is that, you know, outcast in this market and everyon ...
X @Sei
Sei· 2025-08-30 21:20
On-Chain Asset Expansion - Sei Network aims to bring a wide range of traditional financial assets on-chain, including stablecoins, treasuries, ETFs, GDP data, stocks, money markets, mutual funds, derivatives, corporate bonds, commodities, private equity, and index funds [1] Speed and Efficiency - Sei Network emphasizes faster transaction speeds for all on-chain assets [1]
X @Sei
Sei· 2025-08-30 15:11
Onchain Assets - Everything is coming onchain, including Stablecoins, Treasuries, ETFs, GDP Data, Stocks, Money Markets, Mutual Funds, Derivatives, Corporate Bonds, Commodities, and Private Equity [1] Blockchain Platform - Everything moves faster on Sei, indicated by the ticker symbol ($/acc) [1]
SEC to Clarify Which Digital Tokens Are Securities
Bloomberg Technology· 2025-08-29 19:42
Crypto Regulation & Innovation - Project Crypto aims to modernize regulation for decentralized finance innovations [1][4] - The industry seeks clarity on classifying tokens as securities [1][9] - The SEC is working with the CFTC on crypto regulation, including the CFTC's "Crypto Sprint" [4] - The SEC aims to provide commission-level guidance on what constitutes a security in the crypto space, based on the Howey test [9][10] - The SEC is focused on disclosure and ensuring companies truthfully market crypto products, rather than endorsing specific investments [7] Enforcement & Oversight - The SEC has ongoing crypto-related investigations and actions [14] - The SEC receives nearly 45,000 tips, complaints, and referrals annually, with a portion related to crypto [16] - The SEC has shifted its cyber and crypto unit to a more broadly focused tech unit [15] Market Participants & Assets - Companies are exploring adding crypto to their treasury or creating new ETFs [5][8] - The industry is interested in whether tokens like Solana, XRP, or Dogecoin can be included in ETFs [8] Disclosure Requirements - Investors holding over 5% of a company's stock may require additional disclosures if they are actively directing the company [20][22]
Crill: Valuations for small caps are closely in line with historical averages
CNBC Television· 2025-08-29 11:20
Small Cap Characteristics & Performance - Small caps constitute approximately 10% of the United States market capitalization [1] - Historically, small caps have outperformed large caps by about 1.5% to 2% per year globally [3] - Small caps are currently trading at about 18 times forward earnings [6] Valuation & Investment Considerations - Small cap valuations are generally in line with their historical averages, offering a potential diversification benefit against high valuations in large cap growth companies [2][5] - Investors often express concerns about increasing valuations, particularly in US large cap companies [5] - A significant portion of small cap returns is driven by a small subset of stocks, making broad diversification crucial [8][9] ETF Strategies & Active Management - Flexibility is key in small cap investing, aiming to hold companies poised for higher expected returns [10] - Companies with high valuations, low profitability, and high balance sheet asset growth tend to underperform by 8% to 10% per year [11] - Some ETFs employ a rules-based approach with exclusions to avoid companies with lower expected returns, differentiating them from traditional index solutions [11][12]